Concord, CA, June 10, 2013 – Biocare Medical is proud to announce the availability of a new line of Supernova antibodies. Supernovas contain a higher antibody concentration than standard predilutes, providing versatility to a client’s current test menu. At Biocare, we aim to enable the client to consider all options and determine the most optimal product and protocol that best fits their IHC needs.
Clients now have the option of preserving limited tissue specimens while still providing multi-antigen identification in approximately the same time as an antibody cocktail. This is achieved by using Supernova antibodies in sequential incubations combined with Biocare’s double stain detection. Unique cocktails can also be created with ease as Supernova antibodies have been prepared in optimal diluents for specific tissue types. Additionally, Supernova antibodies only require between 10-20 minute incubations, which can shorten protocol time.
Biocare is introducing popular IHC antibodies in prostate, breast, and lung cancers as well as for infectious disease in Supernova format. Widely used prostate cancer IHC markers now available in 2X and 3X Supernova formats include AMACR, CK HMW [34BE12], Cytokeratin 5/14, ERG, P504S, and p63. Breast markers p120 Catenin and E-cadherin and Herpes Simplex Virus 1 and 2 are now available separately as 2X Supernovas. Look for more antibodies coming soon, new releases can be found online at www.biocare.net/supernova.
About Biocare Medical
Biocare Medical, LLC is an innovator in developing and supplying world class automated immunohistochemistry (IHC) instrumentation, and the full range of reagents for IHC and ISH lab testing. Biocare Medical is the market leader in simultaneous Multiplex IHC and antibody development, which aids in the assessment of clinical cases and accelerates turnaround time. The company’s customers include clinical histology laboratories, pharmaceutical companies, CROs, and biotechnology companies as well as academic, government, military, and other non-profit laboratories. Biocare Medical offers an expanding portfolio of integrated products to address the rapidly growing cancer and infectious disease diagnostic and research markets using tissue immunostaining and in situ hybridization methods. Biocare Medical is headquartered and has manufacturing facilities in Concord, California, and has a global distribution network. For more information, please visit www.biocare.net.